Western Australia has taken a significant step forward in the early detection of rare diseases, with newborn screening for X-linked adrenoleukodystrophy (X-ALD) officially commencing on 3 August 2026.
Delivered through a collaboration between the Child and Adolescent Health Service (CAHS), Office of Population Health Genomics (OPHG), and PathWest, the new screening program will enable babies born in Western Australia to be tested for the rare genetic condition shortly after birth.
